finance.yahoo.com
Positivefinance.yahoo.com ·
ubs says mckesson mck fy27 211142088
MEDICALTAX_ECON_PRICETAX_FNCACT_PEERSGENERAL_HEALTH
Topic context
This topic has been covered 231872 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedAnalyst rating changes on McKesson (MCK) reflect mixed Q4 but positive FY27 outlook. No direct commodity or supply chain disruption; impact is stock-specific via earnings and guidance. Weak commercial mechanism beyond equity analyst sentiment.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- UBS raised McKesson price target to $1,050 from $1,000, Buy rating.
- BofA lowered price target to $900 from $1,000, Buy rating.
- McKesson reported 18% growth in adjusted EPS for fiscal 2026.
- Operating cash flow of $6.2 billion and $5.1 billion returned to shareholders.
- Expanded Ambient Scribe technology to over 1,900 providers.
Related stories
finance.yahoo.com
zillow zg q1 2026 earnings 225404880
finance.yahoo.com
nve nvec q4 2026 earnings 221728418
finance.yahoo.com
oncology institute q1 earnings call 050614985
finance.yahoo.com
barrett bbsi q1 2026 earnings 221818315
economictimes.indiatimes.com